News
Cellmid (ASX: CDY) has changed its name to Anagenics - AN1 (ASX: AN1).
Below are the previous articles from Cellmid (ASX: CDY):
RELATED STOCKHEAD STORIES
Health & Biotech
Check Up: Fundie says ‘buy the dip’ as biotech loses shine amid pandemic rebound
Health & Biotech
ASX Health Stocks: M&A winds blow as API gets an upgraded offer from Wesfarmers, jumps 15pc
News
ASX Small Cap Lunch Wrap: Who’s teaming up for defence deals today?
News
10 at 10: These ASX stocks are lifting off this morning
Health & Biotech
Cannabis, medtech, telehealth – could any of these health microcaps be the next multi-bagger?
News
Last Orders: Small caps hit another 12-year high ahead of holiday
Health & Biotech
The health stocks still taking a hit from COVID-19
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
News
Weekly ASX small cap wrap: ‘Biscuit diplomacy’ is now a thing
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
ATO blocks biotech access to Jobkeeper wage subsidy
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Cancer clinical trials continue as others are shut down on COVID-19 fears
News
Here’s where Predictive Discovery’s 733pc rise in 1 day sits in the record books
Health & Biotech
Zelira, PolyNovo prove even a pandemic can’t stand in the way of good clinical results
News
